Extracellular volume measured by whole body CT scans predicts chronic cardiotoxicity in breast cancer patients treated with neoadjuvant therapies based on anthracyclines: A retrospective study.
R RosenfeldS RiondinoM CerocchiA LucianoG IdoneD LecisF IlluminatoA TolomeiF TorinoM ChiocchiM RoselliPublished in: Breast (Edinburgh, Scotland) (2024)
WB-CT scans performed during oncological reassessment in patients at high-risk of recurrence could be used for CTRCD screening in cardiovascular low-risk patients, especially in aging patients with mECV values above 35 %.